Pancreatic cancer is expected to become the second leading cause of the cancer related deaths in the USA by 2020. A genetically engineered mouse model (KPC) offers an alternative to transplantation models for preclinical therapeutic evaluation as it expresses mutations similar to human pancreatic cell. Magnetic resonance imaging can be used to monitor tumor microenvironment in variety of tumors. The goal of this study was to monitor tumor microenvironment in KPC mouse model during the early stages of tumor development.
This abstract and the presentation materials are available to members only; a login is required.